cliffwatch

ripretinib · Deciphera Pharms · NDA 213973

Qinlock

Earliest generic entry, as listed
6 Oct 2042

Blocked by patent: US 11779572. Only method-of-use patents remain, so a generic may carve out the protected indication and enter earlier.

Listed patents · 42 unexpired

PatentClaimsExpires
US 11779572use U-37146 Oct 2042
US 11969414use U-38978 Feb 2041
US 11185535product30 Dec 2040
US 11395818product30 Dec 2040
US 11576903product30 Dec 2040
US 11612591product30 Dec 2040
US 11793795product30 Dec 2040
US 11801237product, use U-321930 Dec 2040
US 11844788product30 Dec 2040
US 11850240product30 Dec 2040
US 11850241product30 Dec 2040
US 11896585product30 Dec 2040
US 11903933product30 Dec 2040
US 11911370product30 Dec 2040
US 11918564product30 Dec 2040
US 11969415use U-321930 Dec 2040
US 12023328use U-395730 Dec 2040
US 12064422use U-321930 Dec 2040
US 12213967product30 Dec 2040
US 12213968product30 Dec 2040
US 12226406product30 Dec 2040
US 12318374product30 Dec 2040
US 12708617use U-321930 Dec 2040
US 10966966use U-315312 Aug 2040
US 11266635use U-333012 Aug 2040
US 11344536use U-338112 Aug 2040
US 11426390use U-341612 Aug 2040
US 11433056use U-342312 Aug 2040
US 11529336use U-338212 Aug 2040
US 11534432use U-344212 Aug 2040
US 11576904use U-353712 Aug 2040
US 11813251use U-375012 Aug 2040
US 12023325use U-396012 Aug 2040
US 12023326use U-395912 Aug 2040
US 12023327use U-395812 Aug 2040
US 12059410use U-315312 Aug 2040
US 12059411use U-397112 Aug 2040
US 12295944use U-418312 Aug 2040
US 12318373use U-419112 Aug 2040
US 8461179substance, product15 May 2034
US RE48731use U-32197 Jun 2032
US 8188113substance, product27 Jul 2030

Exclusivities · 1 unexpired

ODE-298orphan drug (7 years)15 May 2027

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products covered · 1

NDA · productFormStrengthListed expiry
213973 · 001 · RLDtablet, oral50MG6 Oct 2042